13400
Blog

Running AI at Scale: Why Infrastructure, Not Algorithms, Drives Value

Everyone agrees AI has potential. But the health systems that succeed are ones who invest in the infrastructure to scale it. Real clinical AI isn’t about algorithms alone. It’s about how they’re run, where they show up and how their impact is measured.

We’ve spent years building our aiOS™ platform with four layers that do more than surface AI results. It orchestrates them. It monitors them. It makes them usable across the enterprise. Here’s what that looks like, and why each layer is critical to success.

Layer 1: A Way to Run AI

At the core of any platform is the ability to ingest, normalize and orchestrate data across imaging, EHR and clinical systems. That sounds simple. It’s not. You also need to integrate data across different modalities using smart tools that reduce IT effort. Beyond orchestration, the platform must be able to run AI on that data — intelligently and at scale — and monitor performance over time to ensure algorithms remain accurate, consistent and clinically relevant.

Different systems structure data in different ways. Within a single health system, glucose levels might be measured in different units. Imaging descriptions may not reflect the true content of a scan. You need a way to understand the data — not just pull it in — and then apply logic to determine what should be analyzed, when and by which algorithm.

We built this logic ourselves because we had to. Marketplaces typically rely on each vendor to solve this independently, which creates a heavy burden on IT. If a health system wants to deploy 20 different solutions from 20 different vendors, that’s 20 separate data integration projects. It’s just not feasible.

Aidoc does the heavy lifting once, and then makes it available across every use case — with data orchestration, AI analysis and continuous performance monitoring all built into the infrastructure.

Infrastructure Insight: A true clinical AI platform must orchestrate and analyze data in real-time, with built-in monitoring to ensure accuracy over time. Without that, you’re left with disconnected tools that can’t scale or support timely clinical decisions.

Layer 2: A Way to Drive Action

AI only works if it fits within the existing workflow. That’s why we’ve invested deeply in two directions:

  1. Native integrations with HL7, FHIR and DICOM enable bi-directional communication with PACS, EHRs and mobile tools — no workarounds, no toggling and no manual entry. This ensures that AI results are delivered directly into the systems clinicians already use.
  2. Purpose-built interfaces, for every type of user: desktop for radiologists, mobile for interventionalists and care coordination tools for broader clinical teams. These interfaces aren’t siloed — they’re connected. That means a radiologist can trigger downstream actions, like notifying a care team, without ever leaving their own environment. Insights flow across users, not just to them.

All of this is consolidated into a unified workflow. You don’t need 10 different apps to review 10 different findings. We make sure the experience adjusts to the clinician’s role, not the other way around.

Marketplaces, by contrast, offer tools with separate interfaces, timelines and alert mechanisms. I can’t imagine a clinician keeping up with five different logins to make one decision.

Infrastructure Insight: Clinical AI must execute within native systems via HL7, FHIR and DICOM. Without embedded delivery, bidirectional integration and cross-platform connectivity, insights are delayed, fragmented or ignored.

Layer 3: A Way to Measure Impact

You can’t improve what you can’t measure. For AI to deliver real value, health systems need to know what’s working, for whom and under what conditions. That begins with metrics tied to clear goals, whether it’s reducing treatment delays, improving decisions or speeding up time-to-diagnosis.

An effective measurement strategy spans:

  • AI Performance: sensitivity, specificity, PPV, prevalence
  • Value: turnaround time, length of stay, etc. 
  • Engagement: user adoption, user feedback

But numbers alone aren’t enough. Real insight comes from understanding how AI functions in daily practice. Are clinicians engaging? Is the AI surfacing meaningful findings? Is it helping — or hindering — workflow?

That’s why we built a unified analytics layer for real-time visibility. Health systems can track adoption, drill into usage by role and tie AI performance to outcomes. These insights support better decisions, stronger training and clearer ROI stories.

Marketplace vendors rarely offer this depth. Without usage tracking or performance validation, it’s hard to improve — or prove — anything. And that’s a barrier to lasting adoption.

Infrastructure Insight: If you can’t track impact, you can’t justify the investment. That’s why measurement is embedded into every aspect of our aiOS™ platform.

Layer 4: The AI Use Cases

Yes, algorithms matter. But they only matter if they’re deployed on top of the right infrastructure.

We support a growing ecosystem of AI: some we’ve built, some from partners and algorithms developed by health systems themselves. However, we don’t offer anything we can’t validate, monitor and support at scale. That’s the difference between a governed platform and an open marketplace.

Marketplaces focus on volume — more tools, more choices — but more doesn’t mean better. If every tool has its own interface, its own integration and no performance oversight, you’re left with complexity, not value.

Scaling clinical AI isn’t about adding more algorithms. It’s about removing friction:

  • Ingesting data from across the system
  • Routing insights to the right teams, at the right time
  • Driving action inside existing workflows
  • Measuring what’s working and where

This is what it really takes to run AI across an enterprise. Not just once but everywhere. We built the infrastructure first because we’ve seen what happens when you don’t. 

Infrastructure Insight: True scalability requires shared infrastructure. One that can validate, route and monitor every algorithm, regardless of who built it.

Explore the Latest AI Insights, Trends and Research

Headshot of Reut Yalon
Reut Yalon, PhD
Reut Yalon, PhD, is the Chief Product Officer at Aidoc, leading Aidoc’s product group and the company’s product strategy. Since joining Aidoc, Dr. Yalon and her team developed and commercialized dozens of clinical, FDA-cleared products that are widely used daily in healthcare centers around the world, based on a market-leading overarching framework that enables rapid deployment of new products to the market. Prior to joining Aidoc, she held product positions in medical imaging start-ups, with a passion to build products from ideation to commercialization. Dr. Yalon received her post-doctorate and PhD from the Weizmann Institute of Science, where she developed novel imaging methods for non-invasive prenatal clinical applications. A prolific scientist, Dr. Yalon authored over 10 scientific papers and two book chapters.
Reut Yalon, PhD
Chief Product Officer